EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy

Shuguang Zhang iD, Wenying Chen, Jihong Zhou, Qi Liang, Yu Zhang, Ming Su, Zilong Zhang, Jian Qu iD

Journal of Inflammation Research · 2025-03 · Volume 18 · 4335-4357

DOI: 10.2147/jir.s499403 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2025-03. Verfasst von Shuguang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen…. Die Arbeit wurde bisher 116-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

cancer immunotherapyimmune checkpoint blockadeimmune-related adverse eventmonoclonal antibodytreatment strategy

Autor:innen und Institutionen

  • Department of Pharmacy, Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
  • Department of Pharmacy, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
  • Department of Intensive Care Unit, Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
  • Department of Pharmacy, the Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, People's Republic of China.
  • Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, People's Republic of China.

ORCID-Profile: Shuguang Zhang, Jian Qu

Zitieren

APA

Zhang, S., Chen, W., Zhou, J., Liang, Q., Zhang, Y., Su, M., Zhang, Z., & Qu, J. (2025). The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy. Journal of Inflammation Research, Volume 18, 4335-4357. https://doi.org/10.2147/jir.s499403

Vancouver

Zhang S, Chen W, Zhou J, Liang Q, Zhang Y, Su M, et al. The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy. Journal of Inflammation Research. 2025;Volume 18:4335-4357. doi:10.2147/jir.s499403

BibTeX
@article{Zhang2025,
  author = {Zhang, Shuguang and Chen, Wenying and Zhou, Jihong and Liang, Qi and Zhang, Yu and Su, Ming and Zhang, Zilong and Qu, Jian},
  title = {The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy},
  journal = {Journal of Inflammation Research},
  year = {2025},
  volume = {Volume 18},
  pages = {4335--4357},
  doi = {10.2147/jir.s499403}
}
Kostenlos starten →